Cannabis

New neuroimaging research reveals brain changes in adolescents exposed to cannabis prenatally, hinting at significant impacts on cognitive functions and mental health.

Researchers found that cannabidiol (CBD) significantly reduces PTSD-like symptoms in mice by decreasing brain inflammation through activation of CB2 receptors, suggesting potential new treatments for PTSD by targeting neuroinflammation.

New research has found that the timing of cannabinoid use during alcohol withdrawal is key, with cannabinoids increasing anxiety at 4-hour withdrawal but reducing it at 24-hour withdrawal, potentially due to changes in neuroimmune cell activity.

Adolescents with conduct problems and strong peer engagement are more likely to use cannabis in the future. Cannabis use during adolescence may increase hyperactivity and inattention, but these symptoms tend to diminish with age.

New research has found that CBD does not mitigate and may even exacerbate THC’s disruptive effects on brain connectivity, challenging the belief that CBD tempers THC's psychoactive impact.

Cannabis terpenes effectively reduce chronic neuropathic pain, matching morphine's efficacy, and enhance pain relief when combined with morphine without increasing side effects or addiction risk.

Recent research found that cannabidiol reduces cocaine preference in mice and restores gut microbiota diversity disrupted by cocaine, suggesting CBD's potential in treating cocaine addiction.

Cannabis users exhibit weaker neural responses in brain regions related to cognitive flexibility during task-switching, despite showing no significant differences in task performance compared to nonusers.

A recent study found that cannabis use before sex significantly increased orgasm frequency, ease, and satisfaction for women with orgasmic difficulties, benefiting over 70% of participants.

A recent study published in Frontiers in Pediatrics suggests that prenatal cannabis exposure is related to altered early language development within the first year of life.

A recent study found that occasional cannabis users experienced more significant cognitive and psychomotor impairments after smoking than daily users, indicating possible tolerance in frequent users.

Teens using modern, high-potency cannabis are over eleven times more likely to develop serious mental health issues compared to non-users, highlighting urgent concerns as cannabis becomes more widely available.

A study found that a 20 mg dose of cannabinol (CBN) can reduce nighttime awakenings and improve sleep quality, offering potential benefits for those with sleep difficulties.

Recent findings suggest that cannabis and psilocybin may benefit those experiencing chronic pain.

A four-week study of cannabis users suffering from anxiety found that they reported reductions in anxiety over the study period that were comparable to reductions experienced by nonusers.